Roche announces expanded cyclospora testing portfolio
Aug. 6, 2026
As a cyclospora outbreak continues to spread throughout the United States, Roche, in collaboration with subsidiary TIB MOLBIOL, announced the availability of two new flexible and cost-effective research PCR testing options for labs to address the public health impact of the Cyclospora cayetanensis parasite.
What to know:
- The two new tests are used with the LightCycler 480 and LightCycler PRO instruments.
- The LightMix Modular Cyclospora assay (for research use only, or RUO) is for the specific detection of cyclospora only using hydrolysis probe chemistry.
- The LightMix OneTube Gastro Para 2 assay (RUO) includes multiplex, real-time PCR detection of Entamoeba histolytica, Giardia, Dientamoeba fragilis, Cryptosporidium, Blastocystis and Cyclospora cayetanensis.
- The tests complement an existing assay, UC-TIB-Gastro-PARA-2 (RUO), a multiplex, real-time PCR test for high-throughput research, detecting Dientamoeba fragilis, Blastocystis hominis and Cyclospora cayetanensis in a single reaction. It is used with the cobas 5800, 6800 and 8800 systems.
About the Author
LABlineSign up for our eNewsletters
Get the latest news and updates
